yingweiwo

Dehydrogenase

Dehydrogenase

Dehydrogenase related products

Structure Cat No. Product Name CAS No. Product Description
(R,S)-艾伏尼布 V3885 Ivosidenib (AG-120) racemate 1448346-63-1 Ivosidenib racemate (AG120; RG120; AG-120; RG-120;Tibsovo), the racemic mixture ofIvosidenib, is an orally bioavailable andsmall moleculeIDH1 inhibitor that inhibits mutated cytosolic isocitrate dehydrogenase 1 (IDH1).
2H-四唑乙酸,5-[3-[4-(2-溴-5-氟苯氧基)-1-哌啶基]-5-异恶唑]- V0856 MK-8245 1030612-90-8 MK-8245 (MK8245; MK 8245) is a novel and potentliver-targeted inhibitor of stearoyl-CoA desaturase (SCD) with anti-diabetic and anti-dyslipidemic activities.
3-(2',5'-Disulfophenylimino)-3H-phenothiazine sodium V124938 3-(2',5'-Disulfophenylimino)-3H-phenothiazine sodium 1419158-69-2 3-(2',5'-Disulfophenylimino)-3H-phenothiazine sodium is an electron transfer mediator.
3-甲基吡唑 V3151 3-Methylpyrazole 1453-58-3 3-Methylpyrazole (also known as 3-MP) is a weak inhibitor ofalcohol dehydrogenase,which are a group of dehydrogenase enzymes that occur in many organisms and facilitate the interconversion between alcohols and aldehydes or ketones with the reduction of nicotinamide adenine dinucleotide (NAD+ to NADH).
AChE-IN-85 V128171 AChE-IN-85 AChE-IN-85 is an acetylcholinesterase inhibitor with an IC50 value of 0.083 μM.
AGI-5198 V0855 AGI-5198 1355326-35-0 AGI-5198 (also know as IDH-C35; IDHC35; AGI-5198; AGI 5198) is a novel, highly potent and selective inhibitor of IDH1 (isocitrate dehydrogenase 1) R132H/R132C mutants with potential anticancer activity.
AGI-6780 V0862 AGI-6780 1432660-47-3 AGI-6780 (AGI6780; AGI 6780) is a potent and selective inhibitor oftumor-associated mutant IDH2 (isocitrate dehydrogenases 2) R140Q with potential anti-inflammatory activity.
Antibacterial agent 325 V128917 Antibacterial agent 325 Antibacterial agent 325 is an antibacterial agent.
Antibacterial agent 330 V128922 Antibacterial agent 330 3031427-16-1 Antibacterial agent 330 is an antibacterial agent.
ASP9521 V11730 ASP9521 1126084-37-4 ASP9521 is a novel, selective, orally bioavailable inhibitor of 17β-hydroxysteroid dehydrogenase type 5 (17βHSD5; AKR1C3).
BAY-1436032 V4174 BAY-1436032 1803274-65-8 BAY-1436032 is a novel and potent pan-mutant isocitrate dehydrogenase 1 (IDH1) inhibitor both in vitro and in vivo.
BVT-2733 V16006 BVT-2733 376640-41-4 BVT-2733 is a selective 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor, which attenuates obesity and inflammation in diet-induced obese mice.
CVT-10216 V18887 CVT-10216 1005334-57-5 CVT-10216, an isoflavone compound, is a novel, highly potent and selective, reversible inhibitor of aldehyde dehydrogenase 2 (ALDH2) with IC50s of 29 and 1300 nM for ALDH2 and ALDH1, respectively.
DHODH-IN-11 V39998 DHODH-IN-11 1263303-95-2 DHODH-IN-11 (Compound 14b) is a Leflunomide analogue and a weak inhibitor of dihydroorotate dehydrogenase (DHODH) with a pKa of 5.03.
DHODH-IN-28 V133650 DHODH-IN-28 DHODH-IN-28 is a potent fluorescent inhibitor that targets human dihydroorotate dehydrogenase (hDHODH) with an IC50 value of 170 nM.
DSM1465 V134380 DSM1465 3109381-06-5 DSM1465 is a potent and selective inhibitor of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) with an IC50 value of 15 nM and an EC50 value of 1.4 nM against Plasmodium falciparum 3D7 (Pf3D7) parasite.
Flubeneteram V136119 Flubeneteram 1676101-39-5 Flubeneteram is a succinate dehydrogenase inhibitor with an IC50 value of 0.0484 μM.
Isofetamid V138128 Isofetamid 875915-78-9 Isofetamid is a succinate dehydrogenase inhibitor and bactericide.
MDH2-IN-2 V139549 MDH2-IN-2 3047410-41-0 MDH2-IN-2 is an orally effective MDH2 inhibitor with an IC50 value of 5.9 μM.
MEDS700 V139594 MEDS700 2770979-81-0 MEDS700 is a blood-brain barrier-permeable human dihydroorotate dehydrogenase (hDHODH) inhibitor with an IC50 value of 1.5 nM.
Contact Us